Affimed NV Net Worth

Affimed NV Net Worth Breakdown

  AFMD
The net worth of Affimed NV is the difference between its total assets and liabilities. Affimed NV's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Affimed NV's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Affimed NV's net worth can be used as a measure of its financial health and stability which can help investors to decide if Affimed NV is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Affimed NV stock.

Affimed NV Net Worth Analysis

Affimed NV's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Affimed NV's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Affimed NV's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Affimed NV's net worth analysis. One common approach is to calculate Affimed NV's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Affimed NV's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Affimed NV's net worth. This approach calculates the present value of Affimed NV's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Affimed NV's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Affimed NV's net worth. This involves comparing Affimed NV's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Affimed NV's net worth relative to its peers.

Enterprise Value

93.11 Million

To determine if Affimed NV is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Affimed NV's net worth research are outlined below:
Affimed NV generated a negative expected return over the last 90 days
Affimed NV has high historical volatility and very poor performance
Affimed NV has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 8.28 M. Net Loss for the year was (105.94 M) with profit before overhead, payroll, taxes, and interest of 42.87 M.
Affimed NV currently holds about 237.23 M in cash with (110.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.59.
Affimed NV has a frail financial position based on the latest SEC disclosures
Latest headline from insidermonkey.com: Is Affimed N.V. the Best German Stock to Buy Now
Affimed NV uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Affimed NV. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Affimed NV's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
28th of March 2024
Upcoming Quarterly Report
View
28th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
28th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Know Affimed NV's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Affimed NV is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Affimed NV backward and forwards among themselves. Affimed NV's institutional investor refers to the entity that pools money to purchase Affimed NV's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Walleye Trading Advisors, Llc2024-06-30
24.1 K
Commonwealth Equity Services Inc2024-06-30
21.6 K
Abrdn Plc2024-09-30
20.9 K
Dimensional Fund Advisors, Inc.2024-09-30
18.1 K
Jump Financial Llc2024-06-30
17.7 K
Fmr Inc2024-09-30
17.7 K
Blackrock Inc2024-06-30
16.3 K
Clayton Financial Group Llc2024-06-30
15 K
Geode Capital Management, Llc2024-06-30
13.6 K
683 Capital Management Llc2024-06-30
650 K
Morgan Stanley - Brokerage Accounts2024-06-30
559.6 K
Note, although Affimed NV's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Affimed NV's market capitalization trends

The company currently falls under 'Micro-Cap' category with a current market capitalization of 44.59 M.

Market Cap

148.69 Million

Project Affimed NV's profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(1.09)(1.15)
Return On Capital Employed(1.50)(1.42)
Return On Assets(1.09)(1.14)
Return On Equity(1.83)(1.74)
When accessing Affimed NV's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Affimed NV's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Affimed NV's profitability and make more informed investment decisions.
Please note, the presentation of Affimed NV's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Affimed NV's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Affimed NV's management manipulating its earnings.

Evaluate Affimed NV's management efficiency

Affimed NV has return on total asset (ROA) of (0.4931) % which means that it has lost $0.4931 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.2408) %, meaning that it created substantial loss on money invested by shareholders. Affimed NV's management efficiency ratios could be used to measure how well Affimed NV manages its routine affairs as well as how well it operates its assets and liabilities. As of November 22, 2024, Return On Tangible Assets is expected to decline to -1.15. The current year's Return On Capital Employed is expected to grow to -1.42. At present, Affimed NV's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 162.2 M, whereas Intangible Assets are forecasted to decline to about 23.8 K.
Last ReportedProjected for Next Year
Book Value Per Share 3.87  2.02 
Tangible Book Value Per Share 3.87  1.97 
Enterprise Value Over EBITDA(0.64)(0.67)
Price Book Value Ratio 1.46  1.87 
Enterprise Value Multiple(0.64)(0.67)
Price Fair Value 1.46  1.87 
Enterprise Value65.3 M93.1 M
Affimed NV has shown resilience through effective management strategies. Our analysis examines how these strategies influence financial outcomes and investor returns which helps in understanding the stock's long-term potential.
Enterprise Value Revenue
34.1909
Revenue
7.4 M
Quarterly Revenue Growth
(0.90)
Revenue Per Share
0.493
Return On Equity
(1.24)

Affimed NV Corporate Filings

6K
14th of November 2024
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
8th of November 2024
Other Reports
ViewVerify
4th of November 2024
Other Reports
ViewVerify
13A
24th of October 2024
The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934
ViewVerify
Affimed NV time-series forecasting models is one of many Affimed NV's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Affimed NV's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Affimed NV Earnings per Share Projection vs Actual

Affimed NV Corporate Management

Uwe ReuschHead CultureProfile
Denise MuellerChief BoardProfile
RPh PharmDChief OfficerProfile
Arndt MDChief BoardProfile
Angus SmithCFO BoardProfile
Michael WolfHead AdministrationProfile
Andreas MDChief BoardProfile

Already Invested in Affimed NV?

The danger of trading Affimed NV is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Affimed NV is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Affimed NV. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Affimed NV is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Affimed NV is a strong investment it is important to analyze Affimed NV's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Affimed NV's future performance. For an informed investment choice regarding Affimed Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Affimed NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For information on how to trade Affimed Stock refer to our How to Trade Affimed Stock guide.
You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Affimed NV. If investors know Affimed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Affimed NV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.83)
Revenue Per Share
0.493
Quarterly Revenue Growth
(0.90)
Return On Assets
(0.49)
Return On Equity
(1.24)
The market value of Affimed NV is measured differently than its book value, which is the value of Affimed that is recorded on the company's balance sheet. Investors also form their own opinion of Affimed NV's value that differs from its market value or its book value, called intrinsic value, which is Affimed NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Affimed NV's market value can be influenced by many factors that don't directly affect Affimed NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Affimed NV's value and its price as these two are different measures arrived at by different means. Investors typically determine if Affimed NV is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Affimed NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.